Ginkgo Executive's Steady Stock Sales Continue as Share Price Climbs 50%
Rhea-AI Filing Summary
Form 144 filing for Ginkgo Bioworks Holdings details proposed sale of securities by insider Austin Che. Key details:
- Proposed sale of 99 Class A shares through Fidelity Brokerage Services, with aggregate market value of $857.34
- Shares were acquired on October 12, 2022 through restricted stock vesting as compensation
- Extensive trading history shows consistent sales of 99 shares per transaction from March-June 2025
- Sale prices have ranged from $5.16 to $9.51 per share over the past 3 months
- Total shares outstanding: 46,344,630
The planned sale represents a continuation of a systematic selling pattern, with the insider executing regular small-volume transactions. Recent trading shows increasing share prices, with June 2025 transactions averaging higher values than earlier months.
Positive
- None.
Negative
- None.